Who is sponsoring NCT05801380?

NCT05801380 is sponsored by University of the Philippines.

What drugs are being tested in NCT05801380?

Interventions in NCT05801380: AChE inhibitor monotherapy, AChE inhibitor and NMDA receptor antagonist combination therapy.

What condition does NCT05801380 study?

NCT05801380 studies Alzheimer Disease.

Is NCT05801380 still recruiting?

NCT05801380 is currently recruiting now. Last updated 7 January 2025.

Last reviewed 2025-01-07 · How we verify

NCT05801380: MEMORI-AD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Monitoring Drug Efficacy in Patients with Alzheimer's Disease

Recruiting now Last updated 7 January 2025

What this trial tests

trial testing AChE inhibitor monotherapy in Alzheimer Disease in 60 participants. Currently enrolling.

Timeline

14 February 2022

Primary endpoint
14 February 2026

14 February 2026

Quick facts

Lead sponsor	University of the Philippines
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	60
Start date	14 February 2022
Primary completion	14 February 2026
Estimated completion	14 February 2026
Sites	1 location across Philippines

Drugs / interventions tested

AChE inhibitor monotherapy — full drug profile →
AChE inhibitor and NMDA receptor antagonist combination therapy — full drug profile →

Conditions studied

Alzheimer Disease — all drugs for Alzheimer Disease →

Sponsor

University of the Philippines

Who can join

65 and older, any sex, with Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will explore the different factors associated with drug response to acetylcholinesterase (AChE) inhibitor (donepezil) and NMDA receptor antagonist (memantine) in patients with Alzheimer's Disease.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Monitoring drug Efficacy through Multi-Omics Research initiative in Alzheimer's Disease (MEMORI-AD): A protocol for a multisite exploratory prospective cohort study on the drug response-related clinical, genetic, microbial and meta
Climacosa FMM, Anlacan VMM, Gordovez FJA, Reyes JCB, et al · · 2024 · cited 4× · PMID 39608999 · DOI 10.1136/bmjopen-2023-078660
Challenges in community-based recruitment of Alzheimer's disease cases: Experience of the monitoring drug efficacy through multi-omics research initiative in Alzheimer's disease (MEMORI-AD) study.
Climacosa FMM, Ornos EDB, Diwa ERS, Guantia MGR, et al · · 2026 · PMID 41929959 · DOI 10.1177/25424823261431318

Verify or expand the search:

Other recruiting trials for Alzheimer Disease

Currently open trials in the same condition.

NCT07290387 — Tele-Savvy for Latino Caregivers · NA · recruiting
NCT07178210 — Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease · NA · recruiting
NCT07294885 — Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease · NA · recruiting
NCT06937229 — A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) · Phase 3 · recruiting
NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting

Other University of the Philippines trials

Trials by the same sponsor.

NCT06378489 — The Use of Etonogestrel Contraceptive Implant as Treatment for Endometrial Hyperplasia Without Atypia: A Cohort Study · not yet recruiting
NCT05518760 — COVID-19 Effectiveness Study in the Philippines · unknown
NCT05079763 — Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation Dermatitis · NA · recruiting
NCT04766281 — MLC901 in Moderate Traumatic Brain Injury · Phase 4 · unknown
NCT04849637 — Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients · Phase 2 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05801380 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of the Philippines
Last refreshed: 7 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05801380.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing